Nivolumab vs Sildenafil
Nivolumab vs Sildenafil: Overview
This comparison examines the pharmacological differences between Nivolumab and Sildenafil.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Sildenafil: Selective PDE5 inhibitor increasing cGMP.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Sildenafil β 4 hours.
Chemical Properties
Molecular Formula: Sildenafil β C22H30N6O4S.
Molecular Weight: Sildenafil β 474.5800 g/mol.
Type: Nivolumab β Antibody; Sildenafil β Small molecule.